Apri Kit
Product Images NDC 0555-9043

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Apri (NDC 0555-9043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Ethinyl Estradiol, an active ingredient in Apri 28 Day. The diagram illustrates the molecular configuration of this synthetic estrogen used in the combination contraceptive kit by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image 2

Chemical structure diagram of Ethinyl Estradiol, one of the active ingredients in Apri 28 Day, represented by molecular bonds and rings with labeled functional groups.*

FDA Label Image

Image 3

A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) by age group (15-24, 25-34, 35-44, 45-) and smoking status among ever-users and controls. The chart compares rates for ever-users (non-smokers and smokers) and control groups (non-smokers and smokers), showing higher mortality rates in older age groups and among smokers.*

FDA Label Image

Image 4

A forest plot showing effect estimates (OR/RR) with confidence intervals for nine different studies related to contraceptive use. The chart displays each study's point estimate and its confidence interval along the x-axis ranging from -1.5 to 2, with a vertical reference line at 1.0 for comparison.*

FDA Label Image

Image 5

Apri 28 Day kit packaging label showing desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg. The label has a 28-day blister pack layout with four rows labeled Start, Week 2, Week 3, and Week 4, and columns labeled Sunday through Saturday. The first three rows have gray tablets, and the fourth row contains white tablets. The label includes storage instructions and the manufacturer Teva Pharmaceuticals.*

FDA Label Image

Image 6

Packaging label for Apri 28 Day kit by Teva Pharmaceuticals USA, Inc., containing desogestrel and ethinyl estradiol tablets USP at 0.15 mg/0.03 mg strength. The label states the kit includes 6 cyclic tablet dispensers with 28 tablets each, forming a 28-day regimen. Storage instructions and manufacturer details are shown, along with Rx only designation and Teva logo.*

FDA Label Image

Image 7

Apri 28 Day kit containing desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg. The packaging indicates 6 cyclic tablet dispensers with 28 tablets each, labeled for prescription use only. Manufactured by Teva Pharmaceuticals USA, Inc., the carton features the Teva logo and a warning about protection against pregnancy but not against HIV or other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.